Science Explorer Back to mapMap
Discussion
Researcher · Ionis Pharmaceuticals (United States) · United States

Mark J. Graham

Mark J. Graham publishes mostly in Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism, on topics such as Liver Disease Diagnosis and Treatment, Cholesterol and Lipid Metabolism and Lipid metabolism and biosynthesis.

OpenAlex
World rank
#78,656
of 7,710,434 ranked researchers
Rank in United States
#30,325
of 1,627,098
Works
210
Citations
19k
Citations per work
90.9
h-index
67
i10-index 148Top 1.4% in Molecular Biology
Mark J. Graham

What does Mark J. Graham research?

Mark J. Graham's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (23%).

Everything else: 98 works · 46.8% of their workHealth Sciences: 63 works · 29.9% of their workMedicine: 63 works · 29.9% of their workSurgery: 20 works · 9.6% of their workEndocrinology, Diabetes and Metabolism: 16 works · 7.5% of their workPhysiology: 14 works · 6.5% of their workEpidemiology: 13 works · 6.3% of their workLife Sciences: 49 works · 23.3% of their workBiochemistry, Genetics and Molecular Biology: 49 works · 23.3% of their workMolecular Biology: 36 works · 17.1% of their workCancer Research: 13 works · 6.2% of their workTHEIR WORKMark J. Graham210works
Life Sciences23%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else9846.8%
    1. Medicine6329.9%
    1. Biochemistry, Genetics and Molecular Biology4923.3%
  1. 1Molecular Biology17% of their works
  2. 2Surgery10% of their works
  3. 3Endocrinology, Diabetes and Metabolism8% of their works
  4. 4Physiology6% of their works
  5. 5Epidemiology6% of their works
  6. 6Cancer Research6% of their works

Research topics

Which keywords describe Mark J. Graham's research?

The keywords of their largest research topics: Metabolic Syndrome, Atherosclerosis, Cholesterol, Insulin Resistance, Metabolism, Diabetes, Obesity and Statins.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 24 words, with their numbers
  1. Metabolic Syndrome633 topics
  2. Atherosclerosis583 topics
  3. Cholesterol573 topics
  4. Insulin Resistance462 topics
  5. Metabolism402 topics
  6. Diabetes372 topics
  7. Obesity372 topics
  8. Statins332 topics
  9. NAFLD271 topic
  10. NASH271 topic
  11. LXR221 topic
  12. SREBP221 topic
  13. Lipid Droplets201 topic
  14. Triacylglycerol Synthesis201 topic
  15. Cardiovascular Disease191 topic
  16. Glucose Metabolism191 topic
  17. PPARs181 topic
  18. Peroxisome Proliferator-Activated Receptors181 topic
  19. ANGPTL3171 topic
  20. Cardiovascular Disease Prevention171 topic
  21. Cholesterol-lowering171 topic
  22. Lipoprotein Lipase171 topic
  23. Fatty Acid Synthase161 topic
  24. Lipid Metabolism161 topic

Where does Mark J. Graham work?

Mark J. Graham's main affiliation in the publication record is Ionis Pharmaceuticals (United States), United States.

How many publications and citations does Mark J. Graham have?

OpenAlex counts 210 works and 19,092 citations for Mark J. Graham, an h-index of 67, ranking #78,656 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Mark J. Graham

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark J. Graham. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.